Preclinical studies have shown that these exosomes can attenuate liver fibrosis by inhibiting activation of HSCs, regulating macrophage polarization, and suppressing profibrotic signaling pathways like Hedgehog/SMO and STAT3. The gene discussed is STAT3; the disease is Hepatic fibrosis.